1. ‘Selling sickness: influence on influence’, what constitutes good prescribing in 2010?

   • J. W. Foppe van Mil
   • Martine E. C. van Eijk

   Editorial 07 May 2010 Pages: 311 - 311

2. A note of thanks

   • J. W. Foppe van Mil

   Editorial 21 April 2010 Pages: 312 - 313

3. Pharmacotherapeutic review and update of idiopathic nephrotic syndrome in children

   • Silvia Manrique-Rodríguez
   • Cecilia M. Fernandez-Llamazares
   • Maria Sanjurjo-Saez

   Review Article 13 March 2010 Pages: 314 - 321

   

4. Detection of adverse drug reactions through the minimum basic data set

   • Antonio Salmerón-García
   • José Cabeza Barrera
   • Emilia Casado Fernández

   Short Research Paper 06 March 2010 Pages: 322 - 328

5. Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacy

   • Juraporn Pongwecharak
   • Tarakamon Treeranurat

   Short Research Report 26 February 2010 Pages: 329 - 333

   

6. Views of parents and pharmacists following participation in a paediatric pharmacovigilance study

   • Mansour Tobaiqy
   • Derek Stewart
   • James McLay

   Short Research Report 25 February 2010 Pages: 334 - 338

7. Community pharmacists’ views on adverse drug reactions reporting in Malaysia: a pilot study

   • Kang-Nee Ting
   • Dane Michael Stratton-Powell
   • Claire Anderson

   Short Research Report 25 March 2010 Pages: 339 - 342

8. Knowledge and attitudes of American pharmacists concerning sulfonamide allergy cross-reactivity

   • Geoffrey C. Wall
   • Jane E. DeWitt
   • Carrie F. Koenigsfeld

   Short Research Report 23 April 2010 Pages: 343 - 346

9. Substitution of corticosteroid with everolimus after lung transplantation: a pediatric case report

   • Thibaut Caruba
   • Vanida Brunie
   • Brigitte Sabatier

   Case Report 10 March 2010 Pages: 347 - 349

   

10. Highly effective treatment with tacrolimus ointment in an adolescent with oral graft-versus-host disease

    • T. Bauters
    • V. Bordon
    • G. Laureys

    Case Report 04 April 2010 Pages: 350 - 352

    

11. Use of simulated patients to assess the clinical and communication skills of community pharmacists

    • Marjorie C. Weiss
    • Anneka Booth
    • Eva Wong

    Research Article 18 March 2010 Pages: 353 - 361

12. Classification of drug-related problems with new prescriptions using a modified PCNE classification system

    • Patrick M. Eichenberger
    • Markus L. Lampert
    • Kurt E. Hersberger

    Research Article 13 March 2010 Pages: 362 - 372

    

13. Cardiovascular risk screening program in Australian community pharmacies

    • Gregory M. Peterson
    • Kimbra D. Fitzmaurice
    • Rohan L. Rasiah

    Research Article 10 March 2010 Pages: 373 - 380

    

14. Community pharmacists’ perceptions of medicines use reviews and quality assurance by peer review

    • Geoffrey Harding
    • Michael Wilcock

    Research Article 28 March 2010 Pages: 381 - 385

15. Access to children’s medicines in the United Kingdom, Australia and New Zealand in 1998, 2002 and 2007

    • Rajan Ragupathy
    • June Tordoff
    • David Reith

    Research Article 31 March 2010 Pages: 386 - 393

16. Evaluating categorisation and clinical relevance of drug-related problems in medication reviews

    • Anne Gerd Granas
    • Christian Berg
    • Anne Marie Horn

    Research Article 21 April 2010 Pages: 394 - 403

17. Implementation of guidelines for sequential therapy with fluoroquinolones in a Belgian hospital

    • Franky Buyle
    • Dirk Vogelaers
    • Hugo Robays

    Original Research 01 April 2010 Pages: 404 - 410